Jazz Pharmaceuticals Buys GW Pharma For $7.2 Billion

(Video length 00:00:56)

Jazz Pharmaceuticals is buying GW Pharma for $7.2 billion in cash and stock, or $220 per share. CNBC’s Becky Quick reports.

How did you like this article? Let us know so we can better customize your reading experience.


Leave a comment to automatically be entered into our contest to win a free Echo Show.